Insider Transactions in Q3 2021 at Medpace Holdings, Inc. (MEDP)
Insider Transaction List (Q3 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 03
2021
|
Ashley M. Keating Director |
SELL
Open market or private sale
|
Direct |
2,000
-100.0%
|
$390,000
$195.0 P/Share
|
|
Sep 03
2021
|
Ashley M. Keating Director |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$108,000
$54.99 P/Share
|
|
Sep 03
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
604
-0.01%
|
$115,364
$191.82 P/Share
|
|
Sep 03
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
604
-0.01%
|
$115,364
$191.82 P/Share
|
|
Sep 03
2021
|
Susan E Burwig Exec. VP, Operations |
SELL
Open market or private sale
|
Direct |
7,185
-48.0%
|
$1,379,520
$192.67 P/Share
|
|
Sep 02
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
30,234
-0.5%
|
$5,774,694
$191.85 P/Share
|
|
Sep 02
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
30,234
-0.5%
|
$5,774,694
$191.85 P/Share
|
|
Sep 02
2021
|
Susan E Burwig Exec. VP, Operations |
SELL
Open market or private sale
|
Direct |
55,037
-78.62%
|
$10,567,104
$192.16 P/Share
|
|
Sep 01
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
14,304
-0.24%
|
$2,660,544
$186.29 P/Share
|
|
Sep 01
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
14,304
-0.24%
|
$2,660,544
$186.29 P/Share
|
|
Aug 31
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
12,675
-0.21%
|
$2,306,850
$182.04 P/Share
|
|
Aug 31
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
12,675
-0.21%
|
$2,306,850
$182.04 P/Share
|
|
Aug 30
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
12,236
-0.2%
|
$2,239,188
$183.14 P/Share
|
|
Aug 30
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
12,236
-0.2%
|
$2,239,188
$183.14 P/Share
|
|
Aug 27
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
11,840
-0.2%
|
$2,143,040
$181.83 P/Share
|
|
Aug 27
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
11,840
-0.2%
|
$2,143,040
$181.83 P/Share
|
|
Aug 26
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
466
-0.01%
|
$83,880
$180.17 P/Share
|
|
Aug 26
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
466
-0.01%
|
$83,880
$180.17 P/Share
|
|
Aug 25
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
7,622
-0.13%
|
$1,371,960
$180.54 P/Share
|
|
Aug 25
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
7,622
-0.13%
|
$1,371,960
$180.54 P/Share
|
|
Aug 24
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
1,814
-0.03%
|
$326,520
$180.06 P/Share
|
|
Aug 24
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,814
-0.03%
|
$326,520
$180.06 P/Share
|
|
Aug 23
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
1,482
-0.02%
|
$266,760
$180.22 P/Share
|
|
Aug 23
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,482
-0.02%
|
$266,760
$180.22 P/Share
|
|
Aug 18
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
2,301
-0.04%
|
$414,180
$180.49 P/Share
|
|
Aug 18
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
2,301
-0.04%
|
$414,180
$180.49 P/Share
|
|
Aug 17
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
5,246
-0.09%
|
$954,772
$182.1 P/Share
|
|
Aug 17
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
5,246
-0.09%
|
$954,772
$182.1 P/Share
|
|
Aug 16
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
16,817
-0.28%
|
$3,060,694
$182.83 P/Share
|
|
Aug 16
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
16,817
-0.28%
|
$3,060,694
$182.83 P/Share
|
|
Aug 05
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
556
-0.01%
|
$100,080
$180.04 P/Share
|
|
Aug 05
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
556
-0.01%
|
$100,080
$180.04 P/Share
|
|
Aug 04
2021
|
Ashley M. Keating Director |
SELL
Open market or private sale
|
Direct |
1,000
-100.0%
|
$178,000
$178.0 P/Share
|
|
Aug 04
2021
|
Ashley M. Keating Director |
BUY
Exercise of conversion of derivative security
|
Direct |
1,000
+50.0%
|
$54,000
$54.99 P/Share
|
|
Jul 29
2021
|
Tom C King Director |
SELL
Open market or private sale
|
Direct |
226
-45.2%
|
$39,550
$175.74 P/Share
|
|
Jul 29
2021
|
Tom C King Director |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+50.0%
|
$37,500
$75.63 P/Share
|
|
Jul 27
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
131
-0.0%
|
$23,580
$180.93 P/Share
|
|
Jul 27
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
131
-0.0%
|
$23,580
$180.93 P/Share
|
|
Jul 26
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
15,209
-0.25%
|
$2,752,829
$181.47 P/Share
|
|
Jul 26
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
15,209
-0.25%
|
$2,752,829
$181.47 P/Share
|
|
Jul 23
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
18,882
-0.31%
|
$3,417,642
$181.21 P/Share
|
|
Jul 23
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
18,882
-0.31%
|
$3,417,642
$181.21 P/Share
|
|
Jul 22
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
8,516
-0.14%
|
$1,532,880
$180.63 P/Share
|
|
Jul 22
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
8,516
-0.14%
|
$1,532,880
$180.63 P/Share
|
|
Jul 21
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
9,206
-0.15%
|
$1,675,492
$182.42 P/Share
|
|
Jul 21
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
9,206
-0.15%
|
$1,675,492
$182.42 P/Share
|
|
Jul 20
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
10,176
-0.17%
|
$1,862,208
$183.06 P/Share
|
|
Jul 20
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
10,176
-0.17%
|
$1,862,208
$183.06 P/Share
|
|
Jul 19
2021
|
Medpace Investors, LLC > 10% Shareholder |
SELL
Open market or private sale
|
Direct |
1,442
-0.02%
|
$261,002
$181.11 P/Share
|
|
Jul 19
2021
|
August J. Troendle CEO |
SELL
Open market or private sale
|
Indirect |
1,442
-0.02%
|
$261,002
$181.11 P/Share
|